Patient follow-up after discharge after COVID-19 pneumonia: Considerations for infectious control

J Med Virol. 2020 Nov;92(11):2412-2419. doi: 10.1002/jmv.25994. Epub 2020 Aug 21.

Abstract

Coronavirus disease 2019 (COVID-19) represents a significant global medical issue, with a growing number of cumulative confirmed cases. However, a large number of patients with COVID-19 have overcome the disease, meeting hospital discharge criteria, and are gradually returning to work and social life. Nonetheless, COVID-19 may cause further downstream issues in these patients, such as due to possible reactivation of the virus, long-term pulmonary defects, and posttraumatic stress disorder. In this study, we, therefore, queried relevant literature concerning severe acute respiratory syndrome, Middle East respiratory syndrome, and COVID-19 for reference to come to a consensus on follow-up strategies. We found that strategies, such as the implementation of polymerase chain reaction testing, imaging surveillance, and psychological assessments, starting at the time of discharge, were necessary for long-term follow-up. If close care is given to every aspect of coronavirus management, we expect that the pandemic outbreak will soon be overcome.

Keywords: Middle East respiratory syndrome; coronavirus disease 2019; discharge; follow-up; severe acute respiratory syndrome.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • COVID-19 / epidemiology*
  • COVID-19 Nucleic Acid Testing
  • Communicable Disease Control / methods*
  • Disease Management
  • Follow-Up Studies
  • Humans
  • Patient Discharge / statistics & numerical data*